NEOGENSpecialty Chemicals
Neogen Chemicals Ltd — Profit & Loss Statement
₹1112.00
-5.62%
Neogen Chemicals Ltd Profit & Loss Statement (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Tax Effect Of Unusual Items | -4.30 Cr | 0.00 | 0.00 | 0.09 Cr | — |
| Tax Rate For Calcs | 0.31 | 0.32 | 0.30 | 0.22 | — |
| Normalized EBITDA | 140.53 Cr | 118.60 Cr | 110.93 Cr | 86.17 Cr | — |
| Total Unusual Items | -14.08 Cr | 0.00 | 0.00 | 0.39 Cr | — |
| Total Unusual Items Excluding Goodwill | -14.08 Cr | 0.00 | 0.00 | 0.39 Cr | — |
| Net Income From Continuing Operation Net Minority Interest | 34.83 Cr | 35.65 Cr | 49.97 Cr | 44.63 Cr | — |
| Reconciled Depreciation | 27.79 Cr | 22.87 Cr | 16.20 Cr | 11.69 Cr | — |
| Reconciled Cost Of Revenue | 423.06 Cr | 382.49 Cr | 406.84 Cr | 309.82 Cr | — |
| EBITDA | 126.45 Cr | 118.60 Cr | 110.93 Cr | 86.56 Cr | — |
| EBIT | 98.66 Cr | 95.73 Cr | 94.73 Cr | 74.87 Cr | — |
| Net Interest Income | -48.50 Cr | -42.96 Cr | -25.11 Cr | -18.48 Cr | — |
| Interest Expense | 48.50 Cr | 42.96 Cr | 23.70 Cr | 17.80 Cr | — |
| Normalized Income | 44.61 Cr | 35.65 Cr | 49.97 Cr | 44.33 Cr | — |
| Net Income From Continuing And Discontinued Operation | 34.83 Cr | 35.65 Cr | 49.97 Cr | 44.63 Cr | — |
| Total Expenses | 669.03 Cr | 603.49 Cr | 565.06 Cr | 400.04 Cr | — |
| Diluted Average Shares | 2.64 Cr | 2.55 Cr | 2.49 Cr | 2.49 Cr | — |
| Basic Average Shares | 2.64 Cr | 2.55 Cr | 2.49 Cr | 2.49 Cr | — |
| Diluted EPS | 13.20 | 13.96 | 20.03 | 18.70 | — |
| Basic EPS | 13.20 | 13.96 | 20.03 | 18.70 | — |
| Diluted NI Availto Com Stockholders | 34.83 Cr | 35.65 Cr | 49.97 Cr | 44.63 Cr | — |
| Net Income Common Stockholders | 34.83 Cr | 35.65 Cr | 49.97 Cr | 44.63 Cr | — |
| Otherunder Preferred Stock Dividend | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Net Income | 34.83 Cr | 35.65 Cr | 49.97 Cr | 44.63 Cr | — |
| Net Income Including Noncontrolling Interests | 34.83 Cr | 35.65 Cr | 49.97 Cr | 44.63 Cr | — |
| Net Income Continuous Operations | 34.83 Cr | 35.65 Cr | 49.97 Cr | 44.63 Cr | — |
| Tax Provision | 15.33 Cr | 17.12 Cr | 21.06 Cr | 12.44 Cr | — |
| Pretax Income | 50.16 Cr | 52.77 Cr | 71.03 Cr | 57.07 Cr | — |
| Other Non Operating Income Expenses | 4.01 Cr | 7.47 Cr | 0.62 Cr | 0.08 Cr | — |
| Special Income Charges | -14.08 Cr | 0.00 | — | — | — |
| Other Special Charges | 14.08 Cr | — | — | — | — |
| Net Non Operating Interest Income Expense | -48.50 Cr | -42.96 Cr | -25.11 Cr | -18.48 Cr | — |
| Interest Expense Non Operating | 48.50 Cr | 42.96 Cr | 23.70 Cr | 17.80 Cr | — |
| Operating Income | 108.53 Cr | 87.18 Cr | 95.42 Cr | 74.90 Cr | — |
| Operating Expense | 245.97 Cr | 221.00 Cr | 158.22 Cr | 90.22 Cr | — |
| Other Operating Expenses | 153.34 Cr | 136.13 Cr | 70.22 Cr | 29.84 Cr | — |
| Depreciation And Amortization In Income Statement | 27.79 Cr | 22.87 Cr | 16.20 Cr | 11.69 Cr | — |
| Depreciation Income Statement | 27.79 Cr | 22.87 Cr | 15.90 Cr | 11.69 Cr | — |
| Gross Profit | 354.50 Cr | 308.18 Cr | 253.64 Cr | 165.12 Cr | — |
| Cost Of Revenue | 423.06 Cr | 382.49 Cr | 406.84 Cr | 309.82 Cr | — |
| Total Revenue | 777.56 Cr | 690.67 Cr | 660.48 Cr | 474.94 Cr | — |
| Operating Revenue | 777.56 Cr | 690.67 Cr | 660.48 Cr | 474.94 Cr | — |
| Interest Income | — | 7.41 Cr | 3.83 Cr | 0.60 Cr | 0.13 Cr |
| Rent Expense Supplemental | — | 3.84 Cr | 2.99 Cr | — | — |
| Total Other Finance Cost | — | 4.28 Cr | 5.24 Cr | 1.28 Cr | 0.84 Cr |
| Interest Income Non Operating | — | 7.41 Cr | 3.83 Cr | 0.60 Cr | 0.13 Cr |
| Amortization | — | 0.28 Cr | 0.30 Cr | — | — |
| Research And Development | — | 3.49 Cr | 4.70 Cr | 4.70 Cr | — |
| Selling General And Administration | — | 30.46 Cr | 30.74 Cr | 16.24 Cr | 12.84 Cr |
| Selling And Marketing Expense | — | 17.73 Cr | 20.27 Cr | 6.63 Cr | 5.05 Cr |
| General And Administrative Expense | — | 12.73 Cr | 10.47 Cr | 9.61 Cr | 7.79 Cr |
| Rent And Landing Fees | — | 3.84 Cr | 2.99 Cr | — | — |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Neogen Chemicals Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.